Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Raia Drogasil S/A stock

RADL3.SA
BRRADLACNOR0

Price

20.97 BRL
Today +/-
-0.02 BRL
Today %
-0.62 %

Raia Drogasil S/A stock price

BRL
%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Raia Drogasil S/A stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Raia Drogasil S/A stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Raia Drogasil S/A stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Raia Drogasil S/A's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Raia Drogasil S/A Stock Price History

DateRaia Drogasil S/A Price
1/10/202520.97 BRL
1/9/202521.10 BRL
1/8/202521.13 BRL
1/7/202521.35 BRL
1/6/202521.91 BRL
1/3/202520.80 BRL
1/2/202521.76 BRL
12/30/202422.00 BRL
12/27/202422.00 BRL
12/26/202422.54 BRL
12/23/202422.62 BRL
12/20/202422.75 BRL
12/19/202422.69 BRL
12/18/202422.32 BRL
12/17/202423.86 BRL
12/16/202423.30 BRL

Raia Drogasil S/A Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Raia Drogasil S/A, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Raia Drogasil S/A from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Raia Drogasil S/A’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Raia Drogasil S/A. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Raia Drogasil S/A’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Raia Drogasil S/A’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Raia Drogasil S/A’s growth potential.

Raia Drogasil S/A Revenue, EBIT and net profit per share

DateRaia Drogasil S/A RevenueRaia Drogasil S/A EBITRaia Drogasil S/A Net Income
2028e71.31 B BRL5.25 B BRL3.72 B BRL
2027e59.71 B BRL3.73 B BRL2.26 B BRL
2026e53.64 B BRL3.43 B BRL2.15 B BRL
2025e46.69 B BRL2.81 B BRL1.66 B BRL
2024e40.59 B BRL2.33 B BRL1.25 B BRL
202333.97 B BRL2.18 B BRL1.05 B BRL
202229.07 B BRL1.83 B BRL996.11 M BRL
202124.13 B BRL1.37 B BRL751.93 M BRL
202020.07 B BRL993.3 M BRL484.44 M BRL
201917.57 B BRL1.27 B BRL772.24 M BRL
201814.8 B BRL781.06 M BRL502.45 M BRL
201713.21 B BRL792.37 M BRL511.16 M BRL
201611.26 B BRL713.22 M BRL447.69 M BRL
20158.9 B BRL509.68 M BRL340.21 M BRL
20147.39 B BRL318.6 M BRL221.39 M BRL
20136.23 B BRL197 M BRL101 M BRL
20125.38 B BRL195 M BRL105 M BRL
20112.73 B BRL110 M BRL69 M BRL
20102.01 B BRL112 M BRL89 M BRL
20091.72 B BRL105 M BRL75 M BRL
20081.26 B BRL71 M BRL51 M BRL
2007833 M BRL48 M BRL22 M BRL
2006674 M BRL27 M BRL21 M BRL
2005539 M BRL13 M BRL10 M BRL
2004427 M BRL9 M BRL8 M BRL

Raia Drogasil S/A Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B BRL)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B BRL)NET INCOME (B BRL)NET INCOME GROWTH (%)DIV. (BRL)DIV. GROWTH (%)SHARES (B)DOCUMENTS
199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e2027e2028e
0.150.20.220.220.240.260.280.30.350.430.540.670.831.261.722.012.735.386.237.398.911.2613.2114.817.5720.0724.1329.0733.9740.5946.6953.6459.7171.31
-28.2912.82-1.8212.507.415.3610.1813.8623.7726.2325.0523.5951.2636.5916.5036.1197.1815.8318.5820.3826.5117.3812.0318.6714.2420.2420.4716.8819.4715.0414.8811.3219.42
20.3924.1025.4528.7030.0429.1230.1830.6931.3028.3427.6427.4527.2523.3323.1823.8426.3127.7527.6028.5530.5031.1330.1830.0329.5929.3629.8730.3930.0425.1521.8619.0317.0914.31
0.030.050.060.060.070.080.080.090.110.120.150.190.230.290.40.480.721.491.722.112.713.53.994.455.25.897.218.8310.2100000
0000000.010.010.010.010.010.020.020.050.080.090.070.110.10.220.340.450.510.50.770.480.7511.051.251.662.152.263.72
----50.00-33.33150.0060.00-12.5014.2925.00110.004.76131.8247.0618.67-22.4752.17-3.81118.8153.8531.4714.32-1.7653.78-37.3155.1732.625.8218.3133.1229.705.0664.63
----------------------------------
----------------------------------
0.140.140.140.140.140.140.140.140.140.140.140.140.190.180.180.180.320.330.330.331.651.651.651.651.651.721.721.721.7100000
----------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Raia Drogasil S/A Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Raia Drogasil S/A is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M BRL)RECEIVABLES (B BRL)OTHER REC. (M BRL)INVENTORIES (B BRL)OTHER CURRENT LIAB. (M BRL)CURRENT ASSETS (B BRL)TANGIBLE ASSETS (B BRL)LONG-T. INVEST. (M BRL)LONG-T. REC. (M BRL)INTANGIBLE ASSETS (B BRL)GOODWILL (B BRL)OTHER NON-CURRENT ASSETS (M BRL)NON-CURRENT ASSETS (B BRL)TOTAL ASSETS (B BRL)LIABILITIESCOMMON STOCK (B BRL)ADDITIONAL PAID-IN CAPITAL (M BRL)RETAINED EARNINGS (B BRL)OTHER EQUITY (M BRL)UNREAL. GAINS/LOSSES (M BRL)EQUITY (B BRL)LIABILITIES (B BRL)PROVISIONS (M BRL)OTHER SHORT-TERM LIAB. (M BRL)SHORT-TERM DEBTS (M BRL)LONG-TERM DEBT PORTION (B BRL)SHORT-TERM REC. (B BRL)LONG-T. LIAB. (B BRL)DEFERRED TAXES (M BRL)OTHER LIAB. (M BRL)LONG-T. LIABILITIES (B BRL)DEBT (B BRL)TOTAL CAPITAL (B BRL)
19951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                                         
8.92.43.912.111.49.110.115.82319.727.747.1285125.2142.2196.2340167241.9281.19266.05276.63264.87241.57299.23880.36356.12433.54412.32
0.0100.010.010.010.020.020.020.020.030.040.050.050.070.090.110.250.290.330.410.530.710.870.891.141.511.652.233
3.626.53.22.72.31.73.43.13.94.25.413.74650.856.4212.4252.5186.2199.06217.38274.62249.16286.88432.35359.68530.59710.92833.37
0.020.030.030.020.030.030.040.050.060.080.090.130.120.220.260.30.820.971.131.341.652.152.523.093.854.235.126.137.2
0.231.20.40.50.50.51.61.41.41.52.73.36.58.53.710.57.412.516.0118.2920.0524.128.7436.6747.7660.4376.18117.37
0.040.040.040.050.060.060.070.090.10.130.160.230.470.460.560.671.631.691.92.242.693.433.934.535.767.027.729.5811.56
0.060.060.060.060.050.050.050.050.050.060.060.070.080.10.120.150.370.450.540.650.81.011.281.554.815.025.335.575.94
000000000000000000000000000.834.4814.95
0.20.30.50.91.81.31.20.60.40.50.60.81.41.917.127.935.99.711.717.1423.1822.7434.645.9368.99115.05155.73139.66252.37
0000000000000.010.030.020.071.130.370.350.330.340.350.370.380.420.440.530.660.86
000000000000000.02000.80.80.80.820.820.830.830.830.830.961.081.06
4.616.616.717.118.62217.314.513.72.72.31.93.23.33.57.58.112.111.715.5321.3228.1234.1626.9363.52410.3784.19151.13410.48
0.070.070.070.070.070.070.070.060.060.060.060.070.090.130.180.261.541.651.711.812.012.232.542.826.496.817.067.618.53
0.110.120.120.120.130.130.140.150.170.20.230.30.570.60.730.923.173.343.614.054.75.666.467.3512.2513.8314.7817.1920.09
                                                         
0.020.020.020.030.030.030.030.030.030.040.040.040.290.290.290.290.910.910.910.911.811.811.811.812.52.52.52.54
00000000000000000000000000135.5600
0.040.030.040.030.030.030.030.040.040.040.050.060.060.10.150.31.281.331.41.50.791.061.381.641.51.882.162.831.94
000000000000000008.28.340.3318.0161.3252.670.9941.640000
21.925.925.425.124.323.122.121.921.721.320.620.320.119.919.719.513.313.112.9012.57-17.85-18.03-18.21-18.38-18.5514.7811.3314.47
0.080.080.080.080.090.090.090.090.10.10.110.120.370.40.450.62.22.262.332.442.632.913.223.54.034.364.815.345.96
0.010.020.020.020.030.030.030.030.040.070.080.110.10.130.20.190.540.580.670.871.21.621.822.142.653.113.664.265.09
0.60.50.633.33.53.44.45.46.57.711.616.322.731.528.3121.6127.5180.3181.92221.21296.03329.83327.01391.04440.96574.77773.13877.23
4.65.95.74.34.47.66.26.26.97.67.713.222.635.548.546.370.183.762.390.1771.6284.1986.2493.57178.09149.56267.76295.52544.42
00000000000000000000000000000
00000000.020.010.010.020.030.030.020.020.020.060.080.110.130.150.190.260.350.861.11.41.041.57
0.020.030.030.030.040.050.050.060.070.090.120.160.170.210.30.290.790.861.021.281.652.182.492.914.084.85.96.378.08
000000000000.020.030.030.020.030.110.130.160.180.190.280.410.573.524.13.95.185.6
10.53.93.73.63.432.82.72.62.52.32.22.1233.951.76494125.95165.98193.19228.72237.76123.9974.4389.0117.660
000041.10.70.50.50.20.211.84.14.63.812.216.812.27.8339.4664.0976.6795.83453.56430.43168.44220.57382.22
0.010.010.010.010.010000000.020.030.030.030.040.180.210.270.320.390.540.720.94.094.64.165.425.99
0.030.030.030.040.050.050.050.060.070.090.120.180.20.240.320.320.971.081.291.592.042.723.213.828.179.410.0611.7814.07
0.110.120.120.120.130.130.140.150.170.20.230.30.570.640.780.933.173.343.614.044.685.636.447.3212.213.7714.8717.1220.02
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Raia Drogasil S/A provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Raia Drogasil S/A's financial health and stability.

Assets

Raia Drogasil S/A's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Raia Drogasil S/A must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Raia Drogasil S/A after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Raia Drogasil S/A's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B BRL)DEPRECIATION (B BRL)DEFERRED TAXES (M BRL)CHANGES IN WORKING CAPITAL (M BRL)NON-CASH ITEM (B BRL)PAID INTEREST (M BRL)PAID TAXES (M BRL)NET CASH FLOW FROM OPERATING ACTIVITIES (B BRL)CAPITAL EXPENDITURES (M BRL)CASH FLOW FROM INVESTING ACTIVITIES (M BRL)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M BRL)INTEREST INCOME AND EXPENSES (M BRL)NET DEBT CHANGE (M BRL)NET CHANGE IN EQUITY (M BRL)CASH FLOW FROM FINANCING ACTIVITIES (M BRL)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M BRL)TOTAL DIVIDENDS PAID (M BRL)NET CHANGE IN CASH FLOW (M BRL)FREE CASH FLOW (M BRL)SHARE-BASED COMPENSATION (M BRL)
20072008200920102011201220132014201520162017201820192020202120222023
0.020.070.110.120.090.160.140.30.440.60.690.640.780.620.991.191.22
0.010.020.020.030.060.120.160.190.230.270.340.411.041.181.331.521.71
00000000000000000
-3-119-58-106-129-219-36-161-191-382-494-485-854-535-1,180-1,739-2,247
00.010.010.010.010.040.040.030.030.070.10.12-0.220.220.420.711.11
021171310000000000330
00031313014446110311311811120137323368
0.03-0.020.070.050.030.110.310.360.50.560.630.680.751.481.551.681.79
-32-36-49-101-83-259-238-274-384-490-640-702-286-676-855-1,188-1,304
-32-59-48-100143-258-236-270-387-489-639-702-2-673-885-1,229-1,307
0-2310226113-21102833-30-40-2
00000000000000000
16-18-5834264632-897169217-502-32-850-51-33
0-4701250000000-4600-7300
241-76-23101-12-206-49-129-55-1-3-688-223-1,188-375-499
225-2-1-1-7-13-100000000000
0-9-16-31-40-34-29-41-121-153-170-173-186-190-265-324-465
237-160253159-1737439-1510-11-2357581-52477-21
-4.2-60.724.3-49.2-55.1-154.367.585.28116.8565.36-11.49-20.12462.47800.82694.95493.47480.75
00000000000000000

Raia Drogasil S/A stock margins

The Raia Drogasil S/A margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Raia Drogasil S/A. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Raia Drogasil S/A.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Raia Drogasil S/A's sales revenue. A higher gross margin percentage indicates that the Raia Drogasil S/A retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Raia Drogasil S/A's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Raia Drogasil S/A's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Raia Drogasil S/A's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Raia Drogasil S/A. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Raia Drogasil S/A's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Raia Drogasil S/A Margin History

Raia Drogasil S/A Gross marginRaia Drogasil S/A Profit marginRaia Drogasil S/A EBIT marginRaia Drogasil S/A Profit margin
2028e30.04 %7.36 %5.22 %
2027e30.04 %6.24 %3.79 %
2026e30.04 %6.39 %4.01 %
2025e30.04 %6.01 %3.56 %
2024e30.04 %5.75 %3.07 %
202330.04 %6.41 %3.11 %
202230.39 %6.3 %3.43 %
202129.87 %5.68 %3.12 %
202029.36 %4.95 %2.41 %
201929.59 %7.2 %4.4 %
201830.03 %5.28 %3.39 %
201730.18 %6 %3.87 %
201631.13 %6.34 %3.98 %
201530.51 %5.73 %3.82 %
201428.55 %4.31 %3 %
201327.6 %3.16 %1.62 %
201227.75 %3.62 %1.95 %
201126.31 %4.03 %2.53 %
201023.84 %5.59 %4.44 %
200923.18 %6.1 %4.36 %
200823.33 %5.63 %4.05 %
200727.25 %5.76 %2.64 %
200627.45 %4.01 %3.12 %
200527.64 %2.41 %1.86 %
200428.34 %2.11 %1.87 %

Raia Drogasil S/A Stock Sales Revenue, EBIT, Earnings per Share

The Raia Drogasil S/A earnings per share therefore indicates how much revenue Raia Drogasil S/A has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Raia Drogasil S/A earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Raia Drogasil S/A's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Raia Drogasil S/A’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Raia Drogasil S/A's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Raia Drogasil S/A Revenue, EBIT and net profit per share

DateRaia Drogasil S/A Sales per ShareRaia Drogasil S/A EBIT per shareRaia Drogasil S/A Earnings per Share
2028e41.51 BRL0 BRL2.17 BRL
2027e34.76 BRL0 BRL1.32 BRL
2026e31.22 BRL0 BRL1.25 BRL
2025e27.18 BRL0 BRL0.97 BRL
2024e23.62 BRL0 BRL0.73 BRL
202319.82 BRL1.27 BRL0.62 BRL
202216.9 BRL1.06 BRL0.58 BRL
202114.03 BRL0.8 BRL0.44 BRL
202011.67 BRL0.58 BRL0.28 BRL
201910.64 BRL0.77 BRL0.47 BRL
20188.98 BRL0.47 BRL0.3 BRL
20178.01 BRL0.48 BRL0.31 BRL
20166.83 BRL0.43 BRL0.27 BRL
20155.4 BRL0.31 BRL0.21 BRL
201422.45 BRL0.97 BRL0.67 BRL
201318.89 BRL0.6 BRL0.31 BRL
201216.31 BRL0.59 BRL0.32 BRL
20118.58 BRL0.35 BRL0.22 BRL
201011.14 BRL0.62 BRL0.49 BRL
20099.61 BRL0.59 BRL0.42 BRL
20087.12 BRL0.4 BRL0.29 BRL
20074.43 BRL0.26 BRL0.12 BRL
20064.78 BRL0.19 BRL0.15 BRL
20053.82 BRL0.09 BRL0.07 BRL
20043.03 BRL0.06 BRL0.06 BRL

Raia Drogasil S/A business model

Raia Drogasil SA is a Brazilian company specializing in the sale of pharmaceutical and personal care products. The company is based in São Paulo, Brazil, and operates throughout Latin America. Raia Drogasil was founded in 1905 and is now the largest retail company in Brazil specializing in the sale of drugs and personal care products. Raia Drogasil started as a small family business and over the years, through acquisitions and mergers, became one of the largest retailers in Brazil. The company opened its first pharmacy in São Paulo and expanded its presence throughout the entire territory of Brazil. Today, Raia Drogasil operates approximately 2,200 branches in over 25 states in Brazil. Raia Drogasil's innovative business model is focused on digitalized processes and customer service, ensuring a smooth and user-friendly experience for customers. The company has adapted its business operations in the past due to environmental changes and societal trends. For example, Raia Drogasil has recently strengthened its e-commerce business, allowing customers to conveniently and securely order from home. Raia Drogasil SA operates two different brands: Drogasil and Droga Raia. The Drogasil brand is established more in cities, while the Droga Raia brand is active in smaller towns. Both brand branches offer a wide range of health and beauty products, including drugs, supplements, cosmetics, and baby products. Products offered by Raia Drogasil include general health medications such as pain relievers, vitamins, and cough and cold remedies. Additionally, the company also offers a wide range of products for specific health issues, such as products for diabetics, skincare, and women's well-being. They also carry supplements for various needs, such as immune system support, cardiovascular issues, muscle building, and weight loss. Raia Drogasil also provides a wide selection of cosmetic products for body care and beauty, including skincare and haircare products, makeup, and perfumes. Another special offering is the baby and children's department, where you can find a variety of products for babies and children of all ages, such as baby creams, wipes, and milk powder. In summary, Raia Drogasil SA is one of the leading companies in the pharmacy and personal care industry in Brazil. The company specializes in providing health products to its customers and offers a wide range of products for various needs. This includes medications, supplements, cosmetic products, baby products, and much more. Raia Drogasil has also successfully adapted to ever-changing environmental conditions and societal trends to ensure a smooth and user-friendly experience for its customers. Raia Drogasil S/A is one of the most popular companies on Eulerpool.com.

Raia Drogasil S/A SWOT Analysis

Strengths

Raia Drogasil SA is one of the largest pharmaceutical retail companies in Brazil, allowing them to benefit from economies of scale and pricing advantages.

The company has a strong brand presence and a wide network of stores, providing convenience and accessibility to customers.

Raia Drogasil SA has a diversified product portfolio, including prescription drugs, over-the-counter medicines, personal care products, and beauty items, catering to a broad customer base.

Weaknesses

The company heavily relies on the Brazilian market, making it vulnerable to economic fluctuations and political instability in the country.

Raia Drogasil SA faces intense competition in the pharmaceutical retail sector, both from traditional brick-and-mortar stores and online platforms.

The company's profitability may be affected by regulatory changes in the healthcare industry, pricing pressures, and reimbursement policies.

Opportunities

Raia Drogasil SA can capitalize on the growing demand for healthcare products and services in Brazil, driven by an aging population and increased health awareness.

Expansion into e-commerce and digital channels can help the company reach a wider customer base and improve convenience for its customers.

The company can explore partnerships with healthcare providers and insurance companies to enhance its services and differentiate itself from competitors.

Threats

The ongoing COVID-19 pandemic and potential future health crises pose a threat to the company's operations, supply chain, and customer demand.

Increased regulations in the pharmaceutical industry can impact Raia Drogasil SA's operations, requiring compliance with quality standards and pricing regulations.

Changing consumer behavior, such as a shift towards online shopping and preference for generic medications, can pose threats to the company's market share and profitability.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Raia Drogasil S/A Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Raia Drogasil S/A historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Raia Drogasil S/A shares outstanding

The number of shares was Raia Drogasil S/A in 2024 — This indicates how many shares 1.714 B is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Raia Drogasil S/A earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Raia Drogasil S/A's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Raia Drogasil S/A’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Raia Drogasil S/A's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Raia Drogasil S/A stock splits

In Raia Drogasil S/A's history, there have been no stock splits.

Raia Drogasil S/A dividend history and estimates

In 2024, Raia Drogasil S/A paid a dividend amounting to 0.27 BRL. Dividend means that Raia Drogasil S/A distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Raia Drogasil S/A provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Raia Drogasil S/A’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Raia Drogasil S/A's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Raia Drogasil S/A Dividend History

DateRaia Drogasil S/A Dividend
2028e0.34 BRL
2027e0.34 BRL
2026e0.34 BRL
2025e0.34 BRL
2024e0.34 BRL
20230.31 BRL
20220.25 BRL
20210.12 BRL
20200.13 BRL
20190.13 BRL
20180.13 BRL
20170.12 BRL
20160.12 BRL
20150.11 BRL
20140.05 BRL
20130.02 BRL
20120.02 BRL
20110.03 BRL
20100.03 BRL
20090.02 BRL
20080.02 BRL
20070.01 BRL
20060.01 BRL
20050.01 BRL
20040 BRL

Raia Drogasil S/A dividend payout ratio

In 2024, Raia Drogasil S/A had a payout ratio of 36.94%. The payout ratio indicates the percentage of the company's profits that Raia Drogasil S/A distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Raia Drogasil S/A represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Raia Drogasil S/A could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Raia Drogasil S/A's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Raia Drogasil S/A Payout Ratio History

DateRaia Drogasil S/A Payout ratio
2028e38.94 %
2027e38.44 %
2026e38.62 %
2025e39.77 %
2024e36.94 %
202339.17 %
202243.19 %
202128.45 %
202045.86 %
201927.44 %
201841.75 %
201739.63 %
201643.52 %
201552.68 %
20146.75 %
20137.61 %
20127.56 %
201113.68 %
20106.67 %
20095.48 %
20088.46 %
20079.7 %
20063.72 %
20058 %
20043.94 %
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Raia Drogasil S/A.

Raia Drogasil S/A latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/20240.17 BRL0.2 BRL (15.12 %)2024 Q3
6/30/20240.23 BRL0.11 BRL (-50.26 %)2024 Q2
3/31/20240.15 BRL0.11 BRL (-25.68 %)2024 Q1
12/31/20230.15 BRL0.17 BRL (11.04 %)2023 Q4
9/30/20230.17 BRL0.16 BRL (-5.44 %)2023 Q3
6/30/20230.21 BRL0.2 BRL (-2.4 %)2023 Q2
3/31/20230.12 BRL0.11 BRL (-10.22 %)2023 Q1
12/31/20220.15 BRL0.18 BRL (20.44 %)2022 Q4
9/30/20220.13 BRL0.13 BRL (-2.95 %)2022 Q3
6/30/20220.15 BRL0.2 BRL (31.54 %)2022 Q2
1
2
3
4
5
...
7

Eulerpool ESG Scorecard© for the Raia Drogasil S/A stock

Eulerpool World ESG Rating (EESG©)

78/ 100

🌱 Environment

84

👫 Social

79

🏛️ Governance

69

Environment

Scope 1 - Direct Emissions
29,051.3
Scope 2 - Indirect emissions from purchased energy
7,795.26
Scope 3 - Indirect emissions within the value chain
553,207
Total CO₂ emissions
36,846.6
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees64.198
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Raia Drogasil S/A shareholders

%
Name
Stocks
Change
Date
11.45339 % Wells Holding Ltd196,770,44805/31/2024
5.73095 % GL Participa¿¿es, Ltda.98,458,29705/31/2024
5.06348 % BlackRock Institutional Trust Company, N.A.86,991,11205/31/2024
4.99717 % JP Morgan Asset Management85,851,814-2,066,71710/30/2023
4.98818 % Schroder Investment Management Ltd. (SIM)85,697,381-232,56310/9/2024
2.96514 % RBC Global Asset Management (UK) Limited50,941,3861,719,6009/30/2024
2.20200 % The Vanguard Group, Inc.37,830,599-24,1949/30/2024
2.14695 % Schroder Investment Management North America Inc.36,884,76307/31/2024
2.08939 % Invesco Advisers, Inc.35,896,0003,325,2008/31/2024
1.97167 % Fidelity Management & Research Company LLC33,873,557-15,2958/31/2024
1
2
3
4
5
...
10

Most common questions regarding Raia Drogasil S/A

What values and corporate philosophy does Raia Drogasil S/A represent?

Raia Drogasil SA embodies a set of core values and a corporate philosophy that define its operations and success. With a commitment to excellence and customer satisfaction, Raia Drogasil SA values integrity, professionalism, and innovation. The company strives to deliver high-quality products and services, ensuring the well-being and health of its customers. Raia Drogasil SA operates with a customer-centric approach, aiming to provide accessible healthcare solutions and personalized care. With a strong emphasis on teamwork and continuous improvement, Raia Drogasil SA fosters a supportive and dynamic work environment. These values and corporate philosophy define Raia Drogasil SA's commitment to exceptional service and its mission to be a leading player in the healthcare industry.

In which countries and regions is Raia Drogasil S/A primarily present?

Raia Drogasil SA is primarily present in Brazil.

What significant milestones has the company Raia Drogasil S/A achieved?

Raia Drogasil SA, a leading Brazilian pharmaceutical company, has achieved significant milestones over the years. The company has successfully expanded its retail network, solidifying its position as the largest chain of drugstores in Brazil. Raia Drogasil SA has also made noteworthy acquisitions, such as the purchase of Drogasil, which further enhanced its market presence. In addition, the company has consistently reported strong financial performance and steady revenue growth. Raia Drogasil SA's commitment to innovation and customer satisfaction has earned them numerous accolades, including being recognized as one of the most admired companies in Brazil.

What is the history and background of the company Raia Drogasil S/A?

Raia Drogasil SA is a prominent Brazilian retail company specializing in pharmaceutical products. Established in 2011 through the merger of Raia S.A. and Drogasil S.A., the company boasts a rich history and a solid background in the healthcare industry. Raia Drogasil SA operates an extensive network of drugstores across Brazil, providing a wide range of medicines, personal care products, beauty items, and wellness solutions. With a focus on customer satisfaction and convenient accessibility, the company has earned a strong reputation and grown into the largest retail pharmacy chain in the country. Raia Drogasil SA continues to expand its presence and actively contributes to the improvement of healthcare services in Brazil.

Who are the main competitors of Raia Drogasil S/A in the market?

The main competitors of Raia Drogasil SA in the market include major pharmacy chains such as Panvel, Droga Raia, Pague Menos, and Ultrafarma. They compete with Raia Drogasil SA in terms of market share, store network, and product offerings within the pharmaceutical retail industry. These competitors aim to attract customers with competitive prices, a wide range of products, and convenient store locations, similar to what Raia Drogasil SA offers.

In which industries is Raia Drogasil S/A primarily active?

Raia Drogasil SA is primarily active in the retail industry, specifically in the pharmaceutical and healthcare sectors.

What is the business model of Raia Drogasil S/A?

Raia Drogasil SA is a leading Brazilian retail pharmacy chain specializing in the sale of medications, personal care products, cosmetics, and healthcare items. Its business model revolves around providing a wide range of high-quality products at competitive prices through its extensive network of conveniently located stores. Raia Drogasil SA focuses on delivering exceptional customer service and offers an extensive assortment of both generic and branded products to meet the diverse needs of its customers. By leveraging its strong brand recognition and efficient supply chain, the company has successfully established itself as a trusted name in the pharmaceutical retail industry in Brazil.

What is the P/E ratio of Raia Drogasil S/A 2025?

The Raia Drogasil S/A P/E ratio is 21.65.

What is the P/S ratio of Raia Drogasil S/A 2025?

The Raia Drogasil S/A P/S ratio is 0.77.

What is the Quality Investing of Raia Drogasil S/A?

The Quality Investing for Raia Drogasil S/A is 10/10.

What is the revenue of Raia Drogasil S/A 2025?

The expected Raia Drogasil S/A revenue is 46.69 B BRL.

How high is the profit of Raia Drogasil S/A 2025?

The expected Raia Drogasil S/A profit is 1.66 B BRL.

What is the business model of Raia Drogasil S/A

Raia Drogasil SA is a leading Brazilian retail company specializing in the sale of pharmaceuticals and health products. Founded in 1905 in São Paulo, the company has built a strong presence in Brazil over the years and has become known as a reliable provider of health products and services. The business model of Raia Drogasil SA includes a range of divisions and products tailored to the needs of customers. One of the main divisions of the company is the sale of prescription and generic drugs. Here, the company offers a wide range of prescription and over-the-counter medications, as well as an extensive selection of health and wellness products. In addition to the sale of medications, Raia Drogasil SA's business model also includes other important divisions such as health insurance and pharmacies. The company provides comprehensive healthcare services ranging from prescription medications to assistance in creating nutrition plans and disease prevention. Another important component of Raia Drogasil SA's business model is its commitment to digital transformation. The company utilizes modern technologies to enhance its business processes and provide customers with a seamless and personalized experience. The company's online platform includes a wide range of products and services that can be accessed by customers anytime and anywhere. Raia Drogasil SA is also known for its wide range of private label products. The company develops and produces a variety of health and wellness products such as dietary supplements, vitamins, cosmetic products, sunscreens, and more. These products are available in all company branches and offer customers an affordable alternative to branded products. Another important aspect of Raia Drogasil SA's business model is its commitment to future growth and expansion opportunities. The company pursues an aggressive expansion strategy and plans to further expand its presence in Brazil. Key growth initiatives include opening new branches, expanding the product range, and introducing new technologies. In summary, the business model of Raia Drogasil SA is focused on meeting the growing needs of customers for health products and services. The company relies on a wide range of divisions and products, including medications, health insurance, pharmacies, digital transformation, private label products, and growth strategies, to offer its customers a comprehensive package of services. The combination of innovative products and services, a strong presence throughout Brazil, and forward-thinking leadership makes Raia Drogasil SA one of the leading healthcare companies in Brazil. Answer: Raia Drogasil SA is a leading Brazilian retail company specializing in the sale of pharmaceuticals and health products. Its business model includes divisions for medications, health insurance, pharmacies, digital transformation, private label products, and growth strategies. The company aims to meet the growing needs of customers for health products and services through innovative offerings and a strong presence throughout Brazil.

What is the Raia Drogasil S/A dividend?

Raia Drogasil S/A pays a dividend of 0.25 BRL distributed over 4 payouts per year.

How often does Raia Drogasil S/A pay dividends?

Raia Drogasil S/A pays out a dividend 4 times a year.

What is the Raia Drogasil S/A ISIN?

The ISIN of Raia Drogasil S/A is BRRADLACNOR0.

What is the Raia Drogasil S/A ticker?

The ticker of Raia Drogasil S/A is RADL3.SA.

How much dividend does Raia Drogasil S/A pay?

Over the past 12 months, Raia Drogasil S/A paid a dividend of 0.31 BRL . This corresponds to a dividend yield of about 1.47 %. For the coming 12 months, Raia Drogasil S/A is expected to pay a dividend of 0.34 BRL.

What is the dividend yield of Raia Drogasil S/A?

The current dividend yield of Raia Drogasil S/A is 1.47 %.

When does Raia Drogasil S/A pay dividends?

Raia Drogasil S/A pays a quarterly dividend. This is distributed in the months of May, May, August, November.

How secure is the dividend of Raia Drogasil S/A?

Raia Drogasil S/A paid dividends every year for the past 25 years.

What is the dividend of Raia Drogasil S/A?

For the upcoming 12 months, dividends amounting to 0.34 BRL are expected. This corresponds to a dividend yield of 1.64 %.

In which sector is Raia Drogasil S/A located?

Raia Drogasil S/A is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Raia Drogasil S/A kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Raia Drogasil S/A from 12/6/2024 amounting to 0.128 BRL, you needed to have the stock in your portfolio before the ex-date on 10/4/2024.

When did Raia Drogasil S/A pay the last dividend?

The last dividend was paid out on 12/6/2024.

What was the dividend of Raia Drogasil S/A in the year 2024?

In the year 2024, Raia Drogasil S/A distributed 0.308 BRL as dividends.

In which currency does Raia Drogasil S/A pay out the dividend?

The dividends of Raia Drogasil S/A are distributed in BRL.

All fundamentals about Raia Drogasil S/A

Our stock analysis for Raia Drogasil S/A Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Raia Drogasil S/A Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.